The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Linda Karr’s story: Healing after heart transplant surgery
The missing element is partnership
Video
After fainting during a step aerobics class at her local gym, Linda Karr was diagnosed with a congenital heart disease. To help manage the condition, she got a defibrillator implanted, but it felt like a horse was kicking her in the chest every time it shocked her heart back into rhythm.
Over 15 years, Linda experienced increasingly challenging symptoms — struggling to catch her breath, navigate a flight of stairs, or even carry groceries. Eventually, her doctors put her on the heart transplant list. After 2.5 years, Linda underwent a domino transplant surgery.
Managing her post-transplant regimen required an overwhelming arsenal of 44 medications — pills, liquids, and syringes — all to prevent rejection of the donor heart. With the support of her doctors, Linda gradually tapered down to a more manageable 10 medications.
Among these life-saving medications were anti-rejection drugs and antivirals — products that Thermo Fisher Scientific helps to develop and manufacture in partnership with pharmaceutical companies. Today, Linda attributes her continued vitality to these groundbreaking drugs.